Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Financial Flexibility Index
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of CN¥1.90 Billion (operating CF CN¥1.25 Billion minus capex CN¥652.49 Million) represents 0% of total liabilities (CN¥8.77 Billion). Also explore Starlake Bioscience Co Inc Zhaoqing Guan (600866) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Starlake Bioscience Co Inc Zhaoqing Guangdong Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Starlake Bioscience Co Inc Zhaoqing Guangdong across 28 annual periods. Check 600866 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year free cash flow to debt coverage for Starlake Bioscience Co Inc Zhaoqing Guangdong. For the full company profile including market capitalisation, see how much is Starlake Bioscience Co Inc Zhaoqing Guan worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.38x | CN¥3.33 Billion | CN¥1.29 Billion | CN¥8.79 Billion | ▼ -18.6% |
| 2024 | 0.47x | CN¥3.04 Billion | CN¥2.40 Billion | CN¥6.52 Billion | ▲ +30.4% |
| 2023 | 0.36x | CN¥2.40 Billion | CN¥2.03 Billion | CN¥6.73 Billion | ▲ +53.2% |
| 2022 | 0.23x | CN¥2.11 Billion | CN¥1.66 Billion | CN¥9.07 Billion | ▼ -59.1% |
| 2021 | 0.57x | CN¥397.71 Million | CN¥192.63 Million | CN¥697.74 Million | ▼ -20.5% |
| 2020 | 0.72x | CN¥539.88 Million | CN¥249.99 Million | CN¥752.97 Million | ▲ +15.3% |
| 2019 | 0.62x | CN¥370.58 Million | CN¥213.17 Million | CN¥595.95 Million | ▲ +260.2% |
| 2018 | 0.17x | CN¥84.40 Million | CN¥50.69 Million | CN¥488.94 Million | ▲ +14.4% |
| 2017 | 0.15x | CN¥80.66 Million | CN¥40.05 Million | CN¥534.57 Million | ▲ +18.2% |
| 2016 | 0.13x | CN¥81.43 Million | CN¥41.17 Million | CN¥637.90 Million | ▼ -4.4% |
| 2015 | 0.13x | CN¥106.23 Million | CN¥2.75 Million | CN¥795.88 Million | ▲ +279.4% |
| 2014 | 0.04x | CN¥27.70 Million | CN¥-20.22 Million | CN¥787.37 Million | ▼ -46.2% |
| 2013 | 0.07x | CN¥74.46 Million | CN¥-28.16 Million | CN¥1.14 Billion | ▲ +568.5% |
| 2012 | 0.01x | CN¥16.62 Million | CN¥-276.02 Million | CN¥1.70 Billion | ▼ -98.3% |
| 2011 | 0.57x | CN¥925.40 Million | CN¥65.88 Million | CN¥1.62 Billion | ▼ -20.4% |
| 2010 | 0.72x | CN¥501.03 Million | CN¥104.63 Million | CN¥698.07 Million | ▼ -9.7% |
| 2009 | 0.79x | CN¥379.33 Million | CN¥316.73 Million | CN¥477.36 Million | ▲ +131.9% |
| 2008 | 0.34x | CN¥198.90 Million | CN¥148.93 Million | CN¥580.44 Million | ▲ +32.4% |
| 2007 | 0.26x | CN¥157.18 Million | CN¥82.28 Million | CN¥607.29 Million | ▲ +18.9% |
| 2006 | 0.22x | CN¥112.52 Million | CN¥35.14 Million | CN¥516.89 Million | ▼ -8.6% |
| 2005 | 0.24x | CN¥116.60 Million | CN¥46.83 Million | CN¥489.57 Million | ▼ -60.8% |
| 2004 | 0.61x | CN¥249.81 Million | CN¥29.05 Million | CN¥410.86 Million | ▼ -37.6% |
| 2003 | 0.97x | CN¥259.83 Million | CN¥149.70 Million | CN¥266.82 Million | ▼ -32.2% |
| 2002 | 1.44x | CN¥271.37 Million | CN¥183.18 Million | CN¥188.89 Million | ▲ +155.7% |
| 2001 | 0.56x | CN¥138.17 Million | CN¥60.82 Million | CN¥245.97 Million | ▲ +16.0% |
| 2000 | 0.48x | CN¥160.58 Million | CN¥93.41 Million | CN¥331.53 Million | ▼ -47.4% |
| 1999 | 0.92x | CN¥132.42 Million | CN¥52.97 Million | CN¥143.87 Million | ▼ -17.6% |
| 1998 | 1.12x | CN¥184.87 Million | CN¥71.14 Million | CN¥165.54 Million | — |